Interestingly, studies have found that in osteoporosis induced by estrogen deficiency, there is no significant change in the expression of Th effector cytokines in the serum, while the IL-17 signaling pathway can inhibit adipogenesis and the expression of leptin. This evidence concerns the gene IL17A and osteoporosis.